Molecular Imaging CRO

——

 

C-Ray with its molecular imaging technology is capable of conducting studies of radiopharmaceutical marking, in vivo imaging in small and large animals, preclinical efficacy in animals, pharmacokinetics, etc. to provide supportive data for registration of radiopharmaceutical INDs.

Through quality and process explorations with Zr-89-marked antibody conjugates, highly emissive-pure radiodiagnostic drug molecules are obtained and supplied for preclinical animal imaging and biodistribution studies, as well as subsequent IIT imaging in the clinic.

Zr-89

Rapid validation of Zr-89-marked antibodies

Fast lesion cumulation, most efficient distribution and high targeting ability for xenotransplanted tumor models.